Areas: Policy and access
- National Medicines Policy: Collaboration with Member States to formulate, implement, monitor, evaluate and revise national medicines policies.
- Drug selection, management and access to essential drugs: Support is aimed at improving drug management based on the essential medicines concepts, from selection and procurement to distribution. Support is also provided for revision of the national essential medicines list linked with standard treatment guidelines, monitoring and supervision of drug management and development of practical guidelines for procurement.
- Trade and globalization: Technical support for amending of national legislation but incorporates public health safeguards of the Trade Related Aspects of Intellectual Property Rights (TRIPS) Agreement is provided. Dissemination of relevant information is undertaken, such as information on trade globalization and the TRIPS Agreement.
Main activities in 2010-2011
- A Regional Framework for Action on Access to Essential Medicines 2011–2016, was finalized, serving as a guide for strategic collaboration between WHO and the Member States in improving access to essential medicines.
- Thirteen (13) Member States participated in a Consultation on the Regional Framework for Action on Access to Essential Medicines in the Western Pacific 2011-2016, Manila, September 2010 (Brunei Darussalam, Cambodia, China, Fiji, Lao People's Democratic Republic, Malaysia, Mongolia, Palau, Philippines, Samoa, Solomon Islands, Tonga and Viet Nam).
- Ten (10) Member States have been supported to revise or develop national medicines policies and to improve access to essential medicines (Brunei Darussalam, Cambodia, Cook Islands, Fiji, Mongolia, Federated States of Micronesia, Palau, Tuvalu, Tonga, Viet Nam and Vanuatu). Strategic collaboration on universal access had been agreed with China and Viet Nam.
- A regional web based Price Information Exchange (PIEmeds) for selected essential medicines was officially launched, involving seventeen (17) Member States (China, Cook Islands, Fiji, Federated States of Micronesia, Kiribati, Lao People's Democratic Republic, Malaysia, Mongolia, Nauru, Niue, Palau, Papua New Guinea, Samoa, Solomon Islands, Tonga, Vanuatu and Viet Nam). Price of forty (40) key medicines was collected and analyzed.
- WHO/EC/ACP Partnership Project in Pharmaceutical Policies was successfully implemented in fourteen (14) Pacific island countries. Year 6 (2010) was successfully implemented with 100 % implementation rate. A final evaluation of the project has been undertaken in August 2010 with positive results.
- Data collection of a pharmaceutical sector country profile has been completed in sixteen (16) Member States (Brunei Darussalam, Cambodia, Cook Islands, Fiji, Lao People's Democratic Republic, Malaysia, Marshall Islands, Mongolia, Nauru, New Zealand, Palau, Papua New Guinea, Philippines, Solomon Islands, Tuvalu and Vanuatu).
- A workshop on Ensuring Access to Priority Medicines for Mothers and Children, Manila, Philippines, 15 to 17 August 2011 that involved seven (7) Member States (Cambodia, China, Lao People's Democratic Republic, Mongolia, Papua New Guinea, Philippines and Viet Nam) defined country specific feasible options and next actions for improving medicines for Maternal and Child Health (MCH).
- An intercountry Consultation on Improving Access to Essential Medicines, Diagnostics and Medical Devices for the Management of Noncommunicable Diseases was held in Manila, Philippines,
18 to 20 August 2011. Nine (9) countries and area (Brunei Darussalam, Cambodia, China, Hong Kong, Lao People's Democratic Republic, Malaysia, Mongolia, Philippines and Viet Nam) attended the consultation.
- Sixteen (16) Member States (Cambodia, China, Cook Islands, Fiji, Federated States of Micronesia, Kiribati, Lao People's Democratic Republic, Malaysia, Marshall Islands, Mongolia, Palau, Solomon Islands, Philippines, Tuvalu, Vanuatu and Viet Nam) were supported to strengthen medicines supply and management systems by undertaking various activities and initiatives such as assessment of the procurement and supply system, development of standard operating procedures and manuals/guides, review of procurement plans, training of staff, supervisory visits etc.